logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

Dragonfly and Merck Strike $695 Million Deal for Solid Tumors

Oct 1, 2018

Life Science

Innovent Approved to Start US Clinical Trial of CD47 Immunotherapy

Oct 1, 2018

Life Science

Fosun Pharma Officially Announces Plan for Henlius IPO in Hong Kong

Oct 1, 2018

Life Science

Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry

Sep 28, 2018

Life Science

Pfizer Snags FDA Approval for New Lung Cancer Drug Vizimpro

Sep 28, 2018

Life Science

Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences

Sep 28, 2018

Life Science

Cellular Bio to Manufacture Novartis CAR-T Drug in China in $40 Million Deal

Sep 28, 2018

Life Science

F-Prime, Atlas lead cancer startup Akrevia to $30M A round

Sep 27, 2018

Life Science

Lilly Licenses Chugai Pharma’s Oral Diabetes Drug for $50 Million Upfront

Sep 27, 2018

Life Science

Evoke Acquires Navience Healthcare Solutions, LLC

Sep 27, 2018

Life Science

Bellen Chemistry of Beijing, a CRO/CMO, Raises $30 Million-Plus in C Round

Sep 27, 2018

Life Science

Fosun Pharma Acquires China Rights to Stroke Drug in $32.5 Million Agreement

Sep 27, 2018

Life Science

CSPC Pharmaceutical Group Limited and Verastem Oncology Sign Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China

Sep 26, 2018

Life Science

I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs

Sep 26, 2018

Life Science

Flow Pharma Forms JV with Button Capital for China Clinical Trials

Sep 26, 2018

Life Science

$80 Million Series B Financing Funds Morphic Therapeutic’s Next-Generation Oral Integrin

Sep 25, 2018

Life Science

Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec

Sep 25, 2018

Life Science

VenatoRx Pharmaceuticals and Everest Medicines II Limited Announce Exclusive License Agreement for cefepime/VNRX-5133

Sep 25, 2018

Life Science

  • ‹‹ Previous
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada